Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001731122-24-002064
Filing Date
2024-12-30
Accepted
2024-12-30 16:47:20
Documents
10

Document Format Files

Seq Description Document Type Size
1 FORM S-1 e6227_s-1.htm S-1 532177
2 EXHIBIT 5.1 e6227_ex5-1.htm EX-5.1 9244
3 EXHIBIT 23.1 e6227_ex23-1.htm EX-23.1 3809
4 EXHIBIT 107 e6227_ex107.htm EX-FILING FEES 29475
5 GRAPHIC image_001.jpg GRAPHIC 6908
6 GRAPHIC image_002.jpg GRAPHIC 134965
7 GRAPHIC image_004.jpg GRAPHIC 3729
8 GRAPHIC image_005.jpg GRAPHIC 5619
9 GRAPHIC image_006.jpg GRAPHIC 7320
10 GRAPHIC image_007.jpg GRAPHIC 146159
  Complete submission text file 0001731122-24-002064.txt   996159
Mailing Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312
Business Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312 610-727-4597
Virpax Pharmaceuticals, Inc. (Filer) CIK: 0001708331 (see all company filings)

EIN.: 821510982 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-284089 | Film No.: 241590359
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)